PFM
CMRAW

Privium Fund Management’s Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 CMRAW Stock Holding History

Privium Fund Management’s Portfolio CMRAW Stock Details CMRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-42,488
Closed -$922 – 130
2023
Q3 		$922 Hold
42,488
– – ﹤0.01% 114
2023
Q2 		$1.11K Hold
42,488
– – ﹤0.01% 119
2023
Q1 		$1.83K Hold
42,488
– – ﹤0.01% 118
2022
Q4 		$2.1K Hold
42,488
– – ﹤0.01% 128
2022
Q3 		$3K Hold
42,488
– – ﹤0.01% 176
2022
Q2 		$6K Buy
+42,488
New +$6.96K ﹤0.01% 185

Other funds holding CMRAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Privium Fund Management's CMRAW Position: Q4 2023 in Review

Privium Fund Management sold out of Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 (CMRAW) in Q4 2023, closing a stake of 42,488 shares — an estimated $922 sold.

Privium Fund Management first reported a position in CMRAW in Q2 2022 and held it in 6 quarters. The position peaked at $6K in Q2 2022. 3 funds tracked by Wall St. Rank hold CMRAW as of Q4 2023.

  • Privium Fund Management reported no remaining Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position as of Q4 2023 after selling out during the quarter.
  • Privium Fund Management sold 42,488 Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 shares in Q4 2023, an estimated $922.
  • Privium Fund Management first reported a position in Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 in Q2 2022 and held it in 6 quarters.
  • Privium Fund Management's Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 position peaked at $6K in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Warrant expiring 5/19/2027 as of Q4 2023.

Based on Privium Fund Management's 13F filing for Q4 2023, filed 13 Feb 2024.